New dose of Flexeril

OB/GYN News, April 1, 2003

Flexeril (cyclobenzaprine) is now approved in a 5-mg tablet dose for use as an adjunct to rest and physical therapy for the relief of muscle spasm associated with acute, painful, musculoskeletal conditions. The drug is contraindicated in patients during the acute recovery phase of myocardial infarction or in patients with arrhythmias, heart block, conduction disturbances, congestive heart failure, allergies to cyclobenzaprine or other ingredients in Flexeril, hypothyroidism, or current or recent use (within 14 days after discontinuation) of monoamine oxidase inhibitors.

For more information on this product, contact McNeil Consumer & Specialty Pharmaceuticals, 888-440-7903, www.flexeril.info.